FITUSIRAN
UNII SV9W47ZLE1

Substance Identification & Data

This profile provides standardized clinical and technical data for Fitusiran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SV9W47ZLE1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1499251-18-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SV9W47ZLE1

CAS Registry Number

1499251-18-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FITUSIRAN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

SV9W47ZLE1

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C169984

National Cancer Institute reference terminology for clinical and research data.

INN ID

10177

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-138

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Fitusiran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FITUSIRAN

Common Names & Synonyms

FITUSIRAN [INN]

FITUSIRAN [USAN]

FITUSIRAN [WHO-DD]

Systematic Nomenclature

RNA, ((2'-DEOXY-2'-FLUORO)G-SP-GM-SP-(2'-DEOXY-2'-FLUORO)U-UM-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)C-AM-(2'-DEOXY-2'-FLUORO)C-(2'-DEOXY-2'-FLUORO)C-(2'-DEOXY-2'-FLUORO)A-UM-(2'-DEOXY-2'-FLUORO)U-UM-(2'-DEOXY-2'-FLUORO)A-CM-(2'-DEOXY-2'-FLUORO)U-UM-(2'-DEOXY-2'-FLUORO)C-AM-(2'-DEOXY-2'-FLUORO)A), 3'-(((2S,4R)-1-(29-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-14,14-BIS((3-((3-((5-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-1-OXOPENTYL)AMINO)PROPYL)AMINO)-3-OXOPROPOXY)METHYL)-1,12,19,25-TETRAOXO-16-OXA-13,20,24-TRIAZANONACOS-1-YL)-4-HYDROXY-2-PYRROLIDINYL)METHYL HYDROGEN PHOSPHATE), COMPLEX WITH RNA (UM-SP-(2'-DEOXY-2'-FLUORO)U-SP-GM-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)G-UM-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)A-UM-GM-GM-(2'-DEOXY-2'-FLUORO)U-GM-(2'-DEOXY-2'-FLUORO)U-UM-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)C-CM-SP-AM-SP-GM)

SYS